Search research articles
Contact Us
Filters
Showing results (371-380 of 471) with videos related to
Page
of 48
Sort By:
American Journal of Hematology
|
December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
Surbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood
|
January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology
|
August 2, 2021
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia
Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Research Square
|
March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma
Nadine Abdallah, Byron Smith, Thomas White, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood
|
December 17, 2009
Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
Francesca Gay, Suzanne R Hayman, Martha Q Lacy, et al.
Leukemia
|
February 10, 2019
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis
Yi L Hwa, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood Cancer Journal
|
May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.
Page
of 48
Search research articles
Search
Showing results (371-380 of 471) with videos related to
Sort By:
Page
of 48
American Journal of Hematology
|
December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
Surbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood
|
January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology
|
August 2, 2021
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia
Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Research Square
|
March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma
Nadine Abdallah, Byron Smith, Thomas White, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood
|
December 17, 2009
Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
Francesca Gay, Suzanne R Hayman, Martha Q Lacy, et al.
Leukemia
|
February 10, 2019
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis
Yi L Hwa, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood Cancer Journal
|
May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.
Page
of 48